Various factors affect the progression and response to treatment of BC patients, such as the presence or lack of human epidermal growth factor receptor 2 (HER2/neu), progesterone receptor (PR) or estrogen receptor (ER), and lymph node metastasis as well as tumor size.2, 4, 5. This evidence concerns the gene PGR and breast cancer.